UTHR

NASDAQ · Biotechnology

United Therapeutics Corp

Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks

$538.84

+5.90 (+1.11%)

As of Aug 8, 9:39 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 18 82%

Hold 4 18%

Sell 0 0%

Price Target

Analyst Price Target -83.6% upside

Low Target $65.70

Average Target $88.53

High Target $121.74

Current Price $538.84

Current
$538.84

Target
$88.53

$65.70 $88.53 avg $121.74

Scenario Analysis

Bear Case

$65.70

-87.8%

Low target

Base Case

$88.53

-83.6%

Avg target

Bull Case

$121.74

+-77.4%

High target

Risk/Reward

0.9x

Unfavorable

Price in Context

52-Week High

$609.35

-11.6% from high

52-Week Low

$292.34

+84.3% from low

50-Day SMA

$485.49

+11.0% vs SMA

200-Day SMA

$394.55

+36.6% vs SMA

RSI (14)

60.3

Neutral

Target vs 52W High

$88.53

-85.5% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	+4.7%
AMGN Amgen Inc	Hold	43	49%	$190.87	-53.6%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+172.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-11.6%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-55.6%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.4%
BIIB Biogen Inc	Buy	43	67%	$91.45	-56.0%